Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble Drugs

(E-pub Ahead of Print)

Author(s): Kavita Joshi, Akhilesh Chandra, Keerti Jain , Sushama Talegaonkar*.

Journal Name: Pharmaceutical Nanotechnology

Become EABM
Become Reviewer


Most of the active pharmaceutical ingredient used in the management of disease have poor water solubility and offer grueling problems in drug formulation development since low solubility is generally associated with poor dissolution characteristics which leads to poor oral bioavailability. The great challenge for the development of a pharmaceutical product is to create its new formulation and drug delivery system to limit solubility problems of existing drug candidate. Limited drug-loading capacity requires a large amount of carrier material to get appropriate encapsulation of the drug, which is another major challenge in the development of pharmaceutical product which could be resolved by developing nanocrystals (NCs). A significant research in the past few years has been done to develop NCs which helps in the delivery of poorly water soluble drugs via different routes. The technology could continue to thrive as a useful tool in pharmaceutical sciences for the improvement of drug solubility, absorption and bioavailability. Many crystalline compounds have pulled in incredible consideration much of the time, due to their ability to show good physical and chemical properties when contrasted with their amorphous counterparts. Nanocrystals have been proven to show atypical properties compared to the bulk. This review article explores the principles of the important nanocrystallization techniques including NCs characterization and its application.

Keywords: Nanocrystal (NCs), High pressure homogenization, Milling, NanoPure, Dissocube, Application, Dissolution, Crystalline state.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/2211738507666190405182524

Article Metrics

PDF: 2